Pulmonary Embolic Disease

Abstract

Pulmonary embolism is a serious medical condition in which blood clots (thrombi) are released into the venous circulation and eventually find their way to the pulmonary vascular bed. Most of these clots originate in the leg veins as the result of an episode of phlebitis. The larger the volume of blood clot in the pulmonary circulation, the greater is the obstruction to normal blood flow through the lungs and the greater the circulatory compromise. Massive pulmonary embolism is often fatal.

Keywords: pulmonary embolism; pathophysiology; diagnosis; treatment

References

Alpert JS and Dalen JE (1994) Epidemiology and natural history of venous thromboembolism. Progress in Cardiovascular Diseases 36: 417–422.

Alpert JS, Smith RE, Ockene IS et al. (1975) Treatment of massive pulmonary embolism: the role of pulmonary embolectomy. American Heart Journal 89: 413–417.

Becker DM, Philbrick JT and Selby JB (1992) Inferior vena cava filters: indications, safety, effectiveness. Archives of Internal Medicine 152: 1985–1994.

Carter CJ (1994) The pathophysiology of venous thrombosis. Progress in Cardiovascular Diseases 36: 439–446.

Dalen JE and Alpert JS (1975) Natural history of pulmonary embolism. Progress in Cardiovascular Diseases 17: 259–269.

Dalen JE, Banas J Jr, Brooks HL et al. (1969) Resolution rate of acute pulmonary embolism in man. New England Journal of Medicine 280: 1194–1197.

Dalen JE and Hirsch J (eds) (1995) Fourth ACCP consensus conference on antithrombotic therapy. Chest 108(supplement): 225S–522S.

Dalen JE, Haffajee CI, Alpert JS et al. (1977) Pulmonary embolism, pulmonary hemorrhage and pulmonary infarction. New Engl and Journal of Medicine 296: 1431–1435.

de Valk HW, Banga JD, Wester JW et al. (1995) Comparing subcutaneous Danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. A randomized controlled trial. Annals of Internal Medicine 123: 1–9.

Goldhaber SZ, Haire WD, Feldstein ML et al. (1993) Alteplase versus heparin in acute pulmonary embolism: randomized trial assessing right‐ventricular function and pulmonary perfusion. Lancet 341: 507–511.

Lualdi JC and Goldhaber SZ (1995) Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implication. American Heart Journal 130: 1276–1282.

Moser KM (1990) Venous thromboembolism. American Review of Respiratory Disease 141: 235–249.

National Heart, Lung and Blood Institute (1970) Urokinase Pulmonary Embolism Trial: Phase 1 results. Journal of the American Medical Association 214: 2163–2172.

Parakos JA, Adelstein SJ, Smith RE et al. (1973) Late prognosis of acute pulmonary embolism. New England Journal of Medicine 289: 55–58.

PIOPED Investigators (1990) Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). Journal of the American Medical Association 263: 2753–2796.

Prediletto R, Paoletti P, Fornai E et al. (1990) Natural course of treated pulmonary embolism. Evaluation of perfusion lung scintigraphy, gas exchange and chest roentgenogram. Chest 97: 554–561.

Thames MD, Alpert JS and Lower RR (1969) Syncope in patients with pulmonary embolism. Journal of the American and Medical Association 238: 2509–2511.

Urokinase Pulmonary Embolism Study Group (1973) The Urokinase Pulmonary Embolism Trial. Circulation 47(supplement 2): 1–108.

Virchow RIK (1860) Cellular Pathology as Based Upon Physiological and Pathological Histology. Twenty lectures delivered in ... 1858. Translated from the 2nd edn of the original by F. Chance. London.

Further Reading

Alpert JS and Dalen JE (1998) Pulmonary embolism. In: Alexander RW, Schlant RC and Fuster V (eds) Hurst's The Heart, 9th edn, pp. 1719–1738. New York: McGraw‐Hill.

Goldhaber SZ (1998) Pulmonary embolism. New England Journal of Medicine 339: 93–104.

Goldhaber SZ and Morpurgo M (1991) Diagnosis, treatment, and prevention of pulmonary embolism: report of the WHO/International Society and Federation of Cardiology Task Force. Journal of the American Medical Association 268: 1727–1733.

Salzman EW (1992) Low‐molecular‐weight heparin and other new antithrombotic drugs. New England Journal of Medicine 326: 1017–1019.

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Alpert, Joseph S(Apr 2001) Pulmonary Embolic Disease. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1038/npg.els.0002117]